Business Wire

NTT

Share
NTT Group to Launch Asia's First Smart City Proof of Concept Collaborating with Cyberview and Allo in Malaysia

As part of the Japanese Ministry of Internal Affairs and Communications’ FY 2019 project "Research on Smart City Model for Solving Social Problems in Malaysia", based on the smart city initiatives which has been started with the City of Las Vegas, United States, NTT Group (Nippon Telegraph and Telephone Corporation (Hereinafter, NTT), NTT Communications Corporation, NTT Ltd., InfoCom Research, Inc., NTT DATA Corporation, NTT COMWARE Corporation) will conduct Asia's one of the first Smart City Proof of Concept (PoC) in the Cyberjaya area of Malaysia from February 2020, in cooperation with local stakeholders. Through this PoC, NTT Group aims to establish a sustainable business model while verifying the possibility of solving social issues in Asia, utilizing the technologies and know-how accumulated in the smart city field in the United States.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200128005904/en/

1. Background

In Asian countries where stable economic growth continues, various social issues associated with economic growth such as traffic jams and environmental problems have become apparent, and the expectations for ICT-based solutions to these issues are growing. Among Asian countries, Malaysia, a country that built up friendly and mutually beneficial bilateral relationship with Japan through the (Look East) policy advocated by the Prime Minister Mahathir bin Mohamad in 1981, is no exception. There are high expectations that Japanese companies will utilize technologies and know-how cultivated globally, to contribute to the resolution of social issues and the economic development of Malaysia.

Cyberjaya is a neighboring city of Kuala Lumpur, the capital of Malaysia, and has attracted many ICT companies as the nucleus of the Multimedia Super Corridor (MSC) which has been proposed during the administration of the 4th Prime Minister, Mahathir bin Mohamad (1990 - 1995). In addition, the 5G network, which was put into trial operation with nation’s first OpenLab being hosted there, has positioned Cyberjaya as a pioneer test area for the smart city concept in Malaysia.
Since the establishment of a group company (NTT MSC Sdn Bhd) in 1997, NTT Group has been active with investments and business development to contribute to the technological development of the country, and has built a strong relationship with local stakeholders over many years. At this time, the collaboration has been focused on solving social issues with ICT.

2. Overview of the PoC

Through field tests using the technology and know-how of smart city solutions which NTT Group has deployed with the City of Las Vegas, U.S.A. since 2018 (*), NTT Group aims to improve the living conditions of citizens and the sustainability of cities through smart cities using ICT, by studying the possibility of solving social problems in Malaysia and building sustainable business models, together with local stakeholders.

*(press release) About the smart city solutions available in Las Vegas, USA
https://www.ntt.co.jp/news2018/1812/181208a.html

(1) Features of Solutions Delivered During the Field Test

Malaysia is a motorized society with road congestion, automobile accidents and dangerous driving occurring on daily basis. This is one of the emerging social problems that a smart city can resolve by conducting data collection and utilization of vehicle information.
During the field test, based on the vehicle monitoring solution that has been provided in the City of Las Vegas since February 2019, NTT Group will customize and provide similar solution to support the needs of local stakeholders. Specifically, by installing cameras at the intersection with the highest traffic volume in Cyberjaya, and analyzing traffic volume and vehicle information, NTT Group aims to reduce traffic congestion, detect stolen vehicles, and support the creation of businesses in the neighborhood.

(2) Points to be verified through PoC

Based on the results of the field test above, the following will be verified through discussions with stakeholders.

1) Challenges and feasibility of smart city solutions deployed in Coty of Las Vegas in terms of system construction and operational aspects in Malaysia
2) Possibility of business model development using the technology (Application Examples: Public Safety, Smart Infrastructure, Commercial Use)
3) Possibility of deployment to ASEAN countries (Reflecting market trends, legal systems, and local stakeholders' needs)

(3) Period and Location of PoC

- Implementation period: February to March 2020
- Implementation location: Cyberjaya, Malaysia

(4) Role of each entity

NTT

Group

NTT

Overall supervision and coordination among group companies

NTT Communications

Supervision of Ministry of Internal Affairs and Communications’ research projects, support for installation of Multi-Orchestrator

NTT Ltd (NTT MSC)

Stakeholders coordination, implementation of PoC and proposal to stakeholders

InfoCom Research

Implementation of surveys, preparing reports, and support of proposal to stakeholders

NTT DATA

Support for deployment and technical of smart city solutions in Las Vegas

NTT COMWARE

Multi-Orchestrator delivery and technical assistance

Local

Stakeholders

Cyberview

(Tech Hub Developer)

Support for implementation of field test, stakeholder coordination, and business model development

Allo

(Infrastructure provider)

Provision of infrastructure for field test (optical fiber)

3. Future Deployment

Based on the results of the PoC, NTT Group will promote the deployment of smart city solutions to Cyberjaya and other cities in Malaysia, as well as to ASEAN countries, with the aim of improving people's living conditions, improving urban sustainability, and realizing a smart society.

About NTT

NTT is a Global Technology and Business Solutions Provider. We help clients accelerate growth and innovate new digital business models of the future. We provide business consulting and technology services for global networks, cybersecurity, managed IT and applications, workplace, datacenter and cloud services all supported by our deep industry expertise and innovation.

As a top five Global IT Services provider, our globally diverse and inclusive workforce supports clients in 80+ countries and regions. This includes 85% of the Fortune Global 100 companies and thousands of other clients and communities. With a 120-year heritage of service, innovation and social responsibility, we always advocate and act for our clients and a sustainable future. For more information on NTT, visit www.global.ntt/

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye